Clinical trialObsUnknown
Pancreatic Cancer Recurrence in the Netherlands
Detection, Treatment and Survival of Pancreatic Cancer Recurrence in the Netherlands
- Outcome
- Outcome unknown
- Phase
- Obs
- Status
- Unknown
- Study type
- Observational
- Start
- 1 January 2014
- Expected end
- 1 July 2023
- Enrollment
- 1,750 participants
- Sites
- 1
- Primary outcomes
- Incidence of PDAC recurrence; Patterns of PDAC recurrence; Treatment of PDAC recurrence; Survival
- Sponsor
- Other
- Results posted
- No
- Last update
- 2 February 2023
These are registry fields. A trial card, with population, design, endpoints and result direction each tied to a quote, is not in the data yet.
Ask this document
Answers come only from this document’s own text, as highlighted quotes. If it doesn’t say, you are told so instead of given a guess.
Try
Source text
Brief summary public domain (ClinicalTrials.gov)
The aim of this nationwide, observational cohort study is to evaluate current surveillance strategies after primary resection of pancreatic ductal adenocarcinoma (PDAC) in the Netherlands, with regard to the detection, treatment and survival of PDAC recurrence.